Open original FDA record ↗Recall record
- FDA identifier
- Z-0474-2019
- Company in FDA record
- Boston Scientific Corporation
- FDA record creation date
- Nov 16, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Experienced accelerated battery depletion and a shortened replacement interval due to latent internal battery malfunctions.
Source facts
- Action
- The firm, Boston Scientific, sent an "Important Medical Device Information" letter to customers on November 5, 2018 by hand, email via our sales representatives or Federal Express or Courier. The letter described the product, problem and actions to be taken. We will reconcile that 100% of the identified customers /customer representatives signed for the letter, or the letter has been confirmed to be delivered. Boston Scientific will post the product advisory letter on our website, within the Product Performance Resource Center located @ www.bostonscientific.com/en-US/pprc/product-advisories.html. The customers were instructed to do the following: Your doctor has been notified to look for this possible change, so please go to all scheduled defibrillator checks and clinic visits. As always, if you or your family hear beeping from your device, please contact your heart clinic as soon as possible. Your doctor can confirm your ability to hear and recognize this sound during an appointment. If you have additional questions regarding this information or would like to report a clinical event, please contact your Boston Scientific representative or Technical Services, or the Recall Contact at 651-582-3494 or email: Heather.Young@bsci.com.
- Initiated
- 2018-11-01
- Root cause
- Device Design
- Terminated
- 2019-11-04
- Distribution
- US Nationwide Distribution: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
- Recall number
- Z-0474-2019
- Recall status
- Terminated
- CDRH record ID
- 168782
- FDA record created
- 2018-11-16
- Recall event number
- 81471